Condition
Pain, Head
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
Early P 1 (1)
P 1 (1)
P 3 (1)
Trial Status
Completed3
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03223298Phase 3CompletedPrimary
Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles
NCT05407402Not ApplicableUnknownPrimary
Laughter Yoga on Pain and Comfort in Individuals Diagnosed With Migraine
NCT04217616Completed
Pain Perception of People Who Are Unable to Have Headache
NCT03606707Early Phase 1UnknownPrimary
Efficacy of Fluoroscopic Guided Atlantoaxial Joint Injection on Head and Neck Pain and Sleep Quality in RA Patients
NCT03429738Phase 1CompletedPrimary
Single-Dose Bioavailability Study of Two Formulations of Ibuprofen and Pseudoephedrine Hydrochloride Tablets
Showing all 5 trials